Protective effect of dihydromyricetin on LPS-induced acute lung injury
Authors:
- 9 March 2018
- journal article
- research article
- Published by Oxford University Press (OUP) in Journal of Leukocyte Biology
- Vol. 103 (6) , 1241-1249
Abstract
Dihydromyricetin (DHM), a bioactive flavonoid component isolated from Ampelopsis grossedentata, is known to have anti‐inflammatory effect, but the effect of DHM on acute lung injury (ALI) is largely unknown. Here, we investigated the effect of DHM on ALI and the underlying mechanism by bioinformatic analyses and animal experiments. We found that pretreatment with DHM ameliorated lung pathological changes and suppressed the inflammation response in lung tissues after LPS challenge. The potential targets of DHM were predicted by DDI‐CPI and DRAR‐CPI tools and analyzed using the STRING server to predict the functionally related signaling pathways, such as MAPK signaling. Molecular docking calculations indicated that DHM could be embedded tightly into the binding pocket of ERK, JNK, and p38. Furthermore, the activation of MAPK signaling induced by LPS was inhibited by DHM. In conclusion, these findings suggest that DHM may exert its protective effect on ALI by inhibiting MAPK signaling. The present study supports a potential clinical application for DHM in treating ALI and provides a novel design that combines in silico methods with in vivo experiments for drug research.Keywords
Funding Information
- National Natural Science Foundation of China (81470549)
- Natural Science Foundation of Shaanxi Province (2012JQ4025)
- Fundamental Research Funds for the Central Universities (xjj2015076)
This publication has 38 references indexed in Scilit:
- MAP Kinase PathwaysCold Spring Harbor Perspectives in Biology, 2012
- p38 Mitogen-activated protein kinase signaling regulates streptococcal M1 protein-induced neutrophil activation and lung injuryJournal of Leukocyte Biology, 2011
- Smad phosphoisoform signals in acute and chronic liver injury: similarities and differences between epithelial and mesenchymal cellsCell and tissue research, 2011
- The value of the lipopolysaccharide-induced acute lung injury model in respiratory medicineExpert Review of Respiratory Medicine, 2010
- Mesenchymal stem cells for acute lung injury: Preclinical evidenceCritical Care Medicine, 2010
- Pathological roles of MAPK signaling pathways in human diseasesBiochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 2010
- Role of corticosteroids in the management of acute respiratory distress syndromeClinical Therapeutics, 2008
- Acute lung injury and the acute respiratory distress syndrome: a clinical reviewThe Lancet, 2007
- Cytokine Balance in the Lungs of Patients with Acute Respiratory Distress SyndromeAmerican Journal of Respiratory and Critical Care Medicine, 2001
- TGF-β is a critical mediator of acute lung injuryJournal of Clinical Investigation, 2001